IL164942A0 - The use of a protease or a protease inhibitor for the manufacture of medicaments - Google Patents

The use of a protease or a protease inhibitor for the manufacture of medicaments

Info

Publication number
IL164942A0
IL164942A0 IL16494204A IL16494204A IL164942A0 IL 164942 A0 IL164942 A0 IL 164942A0 IL 16494204 A IL16494204 A IL 16494204A IL 16494204 A IL16494204 A IL 16494204A IL 164942 A0 IL164942 A0 IL 164942A0
Authority
IL
Israel
Prior art keywords
protease
medicaments
manufacture
inhibitor
protease inhibitor
Prior art date
Application number
IL16494204A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL16494204A priority Critical patent/IL164942A0/xx
Priority to US11/576,064 priority patent/US20080305097A1/en
Priority to CA002586033A priority patent/CA2586033A1/fr
Priority to EP05801066A priority patent/EP1804828A2/fr
Priority to PCT/IL2005/001121 priority patent/WO2006048862A2/fr
Priority to AU2005302068A priority patent/AU2005302068A1/en
Priority to JP2007538612A priority patent/JP2008520554A/ja
Publication of IL164942A0 publication Critical patent/IL164942A0/xx
Priority to IL182601A priority patent/IL182601A0/en
Priority to NO20072770A priority patent/NO20072770L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
IL16494204A 2004-10-31 2004-10-31 The use of a protease or a protease inhibitor for the manufacture of medicaments IL164942A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL16494204A IL164942A0 (en) 2004-10-31 2004-10-31 The use of a protease or a protease inhibitor for the manufacture of medicaments
US11/576,064 US20080305097A1 (en) 2004-10-31 2005-10-27 Use of Protease or a Protease Inhibitor for the Manufacture of Medicaments
CA002586033A CA2586033A1 (fr) 2004-10-31 2005-10-27 Utilisation d'une protease ou d'un inhibiteur de protease pour la preparation de medicaments
EP05801066A EP1804828A2 (fr) 2004-10-31 2005-10-27 Utilisation d'une protease ou d'un inhibiteur de protease pour la preparation de medicaments
PCT/IL2005/001121 WO2006048862A2 (fr) 2004-10-31 2005-10-27 Utilisation d'une protease ou d'un inhibiteur de protease pour la preparation de medicaments
AU2005302068A AU2005302068A1 (en) 2004-10-31 2005-10-27 The use of a protease or a protease inhibitor for the manufacture of medicaments
JP2007538612A JP2008520554A (ja) 2004-10-31 2005-10-27 医薬の製造のためのプロテアーゼまたはプロテアーゼ阻害剤の使用
IL182601A IL182601A0 (en) 2004-10-31 2007-04-17 The use of a protease or a protease inhibitor for the manufacture of medicaments
NO20072770A NO20072770L (no) 2004-10-31 2007-05-31 Anvendelse av en protease eller en proteasenhibitor for fremstilling av medikamenter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL16494204A IL164942A0 (en) 2004-10-31 2004-10-31 The use of a protease or a protease inhibitor for the manufacture of medicaments

Publications (1)

Publication Number Publication Date
IL164942A0 true IL164942A0 (en) 2005-12-18

Family

ID=36128314

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16494204A IL164942A0 (en) 2004-10-31 2004-10-31 The use of a protease or a protease inhibitor for the manufacture of medicaments
IL182601A IL182601A0 (en) 2004-10-31 2007-04-17 The use of a protease or a protease inhibitor for the manufacture of medicaments

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL182601A IL182601A0 (en) 2004-10-31 2007-04-17 The use of a protease or a protease inhibitor for the manufacture of medicaments

Country Status (8)

Country Link
US (1) US20080305097A1 (fr)
EP (1) EP1804828A2 (fr)
JP (1) JP2008520554A (fr)
AU (1) AU2005302068A1 (fr)
CA (1) CA2586033A1 (fr)
IL (2) IL164942A0 (fr)
NO (1) NO20072770L (fr)
WO (1) WO2006048862A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5257068B2 (ja) 2006-05-16 2013-08-07 小野薬品工業株式会社 保護されていてもよい酸性基を含有する化合物およびその用途
EP2055705A4 (fr) 2006-07-31 2014-08-20 Ono Pharmaceutical Co Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
US9610331B2 (en) 2009-09-08 2017-04-04 Yeda Research And Development Co. Ltd. Methods for hematopoietic precursor mobilization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686900B1 (fr) * 1992-01-31 1995-07-21 Rhone Poulenc Rorer Sa Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant.
FR2751658B1 (fr) * 1996-07-26 1998-10-02 Pasteur Institut Utilisation d'une chemokine (sdf-1) ligand pour le recepteur de lestr/fusin/cxcr4 pour prevenir ou traiter l'infection par des virus de type vih
WO2000009152A1 (fr) * 1998-08-14 2000-02-24 The University Of British Columbia Antagonistes therapeutiques du recepteur de la chimiokine
CA2335109A1 (fr) * 2000-04-12 2001-10-12 Chemokine Therapeutics Corporation Traitement de cellules hematopoietiques avec des agonistes du cxcr4
AR036375A1 (es) * 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos

Also Published As

Publication number Publication date
AU2005302068A1 (en) 2006-05-11
US20080305097A1 (en) 2008-12-11
CA2586033A1 (fr) 2006-05-11
EP1804828A2 (fr) 2007-07-11
WO2006048862A2 (fr) 2006-05-11
JP2008520554A (ja) 2008-06-19
WO2006048862A3 (fr) 2006-08-31
NO20072770L (no) 2007-05-31
IL182601A0 (en) 2007-07-24

Similar Documents

Publication Publication Date Title
IL171938A0 (en) The use of isomalt for the manufacture of a prebiotic
ZA200708811B (en) Use of a sulfonamide compound for improving the pharma-cokinetics of a drug
EP1750696B1 (fr) Inhibiteurs de protéase rétrovirale repoussant leur résistance
EP1732891A4 (fr) Inhibiteurs de la protease retrovirale inhibant la resistance
EP2148693A4 (fr) Antitrypsine alpha-1 n'ayant pas d'activité inhibitrice de sérine protéase significative
LT1981519T (lt) Proteazės slopinimas
IL183101A (en) Use of tetrahydrocannabivarin in drug production
EP1887008A4 (fr) Composé de thièno-triazolo-diazépine et son utilisation médicinale
IL183308A0 (en) Cathepsin cysteine protease inhibitors
TWI365876B (en) Prodrugs of hiv protease inhibitors
EP1764075A4 (fr) Inhibiteur de la production de facteur tissulaire
HK1103645A1 (en) New pharmaceutical uses of the lipase inhibitor
IL183850A0 (en) Hiv protease inhibitors
IL188850A0 (en) Cathepsin k inhibitors
EP1663279A4 (fr) Inhibiteurs de protease modifies
EP1704142A4 (fr) Inhibiteurs de la protease
IL177989A0 (en) Use of transcription factor inhibitor in the manufacture of a medicament
IL182601A0 (en) The use of a protease or a protease inhibitor for the manufacture of medicaments
EP1757282A4 (fr) Utilisation de composes de kaurane dans l'elaboration d'un medicament
EP1736168A4 (fr) Inhibiteur de prothese et preventifs ou remedes pour maladies.
EP1706402A4 (fr) Inhibiteurs des cysteines proteases de type cathepsine
EP1715920A4 (fr) Inhibiteurs de cathepsine cysteine protease
GB0809068D0 (en) The use of serine protease inhibitors
GB0609930D0 (en) Devices for preventing the use of a key
GB0407552D0 (en) Assesing the composition of a fluid